One can only hope, he seems to be quite nagative about Australian IF for some reason.
There are three main issues that surface to keep SP down, supply, competition & regulation. Demand is never an issue, or hasn't been thus far. Supply has dropped down the list recently and it has been competition and regulation in the spot light. I'm confident new competitors are facing an uphill battle, dispite impressive distribution in supermarkets. You can lead a horse to water, but you can't make it drink!
So that leaves the mirky world of Chinese regulation. China is evolving rapidly and so are its laws and regulations. The overall theme of this regulation will help companies like BAL, however, poor communication and execution leaves open the possibility of short term volatility. I'm confident this messy period will pass, and once it has, China will have a more sustainable and better regulated market for IF, be it C2C or B2C.
Nobody said investing was easy!
- Forums
- ASX - By Stock
- BAL
- stock
stock, page-355
-
-
- There are more pages in this discussion • 943 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online